← Back to Search

Prism Adaptation Treatment for Aphasia

N/A
Waitlist Available
Led By Amy D. Rodriguez, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly from baseline to follow-up (study week 7); change from baseline to immediate post-treatment (study week 3 in immediate group, study week 5 in delayed group), change from baseline to two weeks post-treatment (study week 7)
Awards & highlights

Study Summary

This trial will test a new treatment for stroke that targets spatial function, motor function, and pain.

Eligible Conditions
  • Aphasia
  • Spatial Neglect
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Barthel Index
Behavioral Inattention Test- Conventional Subtest
Catherine Bergego Scale via the Kessler Foundation Neglect Assessment Process
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: ImmediateExperimental Treatment1 Intervention
Participants will enter treatment after one week baseline
Group II: DelayedExperimental Treatment1 Intervention
Participants will enter treatment after two week baseline
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prism Adaptation Treatment
2021
N/A
~20

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,591 Total Patients Enrolled
14 Trials studying Aphasia
375 Patients Enrolled for Aphasia
Amy D. Rodriguez, PhDPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA
2 Previous Clinical Trials
68 Total Patients Enrolled
2 Trials studying Aphasia
68 Patients Enrolled for Aphasia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What types of participants are best suited for this investigation?

"To be eligible for this trial, individuals must have suffered a stroke and lie within the ages of 18 to 89. At present, roughly 30 patients are sought after by the clinical team."

Answered by AI

Are there open slots available for participants in this research endeavor?

"Affirmative. According to information on clinicaltrials.gov, this medical study is actively seeking participants; the trial was initially posted in February 15th 2021 and recently updated on January 27th 2022. The investigators are looking for 30 volunteers from 1 specific site."

Answered by AI

What is the size of the population enrolled in this research protocol?

"Yes, records on clinicaltrials.gov suggest that this medical trial has been accepting patients since February 15th 2021 and the data was last modified on January 27th 2022. The study is aiming to enrol 30 people at one location."

Answered by AI

Is admission to the trial restricted solely to individuals under 70 years of age?

"This medical study is only open to individuals aged 18 and under 89."

Answered by AI
~3 spots leftby Apr 2025